 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
Volume 17, Number 2, Issue of January 15, 1997 pp. 796-803
Copyright ©1997 Society for NeuroscienceIncreased Probability of GABA Release during Withdrawal from Morphine
Received Sept. 17, 1996; revised Oct. 29, 1996; accepted Oct. 31, 1996.
Antonello Bonci and John T. Williams The Vollum Institute, L474, Oregon Health Sciences University, Portland, Oregon 97201
Opioid receptors located on interneurons in the ventral tegmental area (VTA) inhibit GABAA-mediated synaptic transmission to dopamine projection neurons. The resulting disinhibition of dopamine cells in the VTA is thought to play a pivotal role in drug abuse; however, little is known about how this GABAA synapse is affected after chronic morphine treatment. The regulation of GABA release during acute withdrawal from morphine was studied in slices from animals treated for 6-7 d with morphine. Slices containing the VTA were prepared and maintained in morphine-free solutions, and GABAA IPSCs were recorded from dopamine cells. The amplitude of evoked IPSCs and the frequency of spontaneous miniature IPSCs measured in slices from morphine-treated guinea pigs were greater than placebo-treated controls. In addition, activation of adenylyl cyclase, with forskolin, and cAMP-dependent protein kinase, with Sp-cAMPS, caused a larger increase in IPSCs in slices from morphine-treated animals. Conversely, the kinase inhibitors staurosporine and Rp-CPT-cAMPS decreased GABA IPSCs to a greater extent after drug treatment. The results indicate that the probability of GABA release was increased during withdrawal from chronic morphine treatment and that this effect resulted from an upregulation of the cAMP-dependent cascade. Increased transmitter release from opioid-sensitive synapses during acute withdrawal may be one adaptive mechanism that results from prolonged morphine treatment.
Key words: ventral tegmental area; dopamine; cAMP; A-kinase; GABAA; tolerance
This article has been cited by other articles:
C. H. Yang, B. H. Lee, and S. H. Sohn
A Possible Mechanism Underlying the Effectiveness of Acupuncture in the Treatment of Drug Addiction
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 257 - 266.
[Abstract] [Full Text] [PDF]
S. Li, M. L. Lee, M. R. Bruchas, G. C. Chan, D. R. Storm, and C. Chavkin
Calmodulin-Stimulated Adenylyl Cyclase Gene Deletion Affects Morphine Responses
Mol. Pharmacol., November 1, 2006; 70(5): 1742 - 1749.
[Abstract] [Full Text] [PDF]
R. Tonini, S. Ciardo, M. Cerovic, T. Rubino, D. Parolaro, M. Mazzanti, and R. Zippel
ERK-Dependent Modulation of Cerebellar Synaptic Plasticity after Chronic {Delta}9-Tetrahydrocannabinol Exposure
J. Neurosci., May 24, 2006; 26(21): 5810 - 5818.
[Abstract] [Full Text] [PDF]
C. P. Ford, G. P. Mark, and J. T. Williams
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.
J. Neurosci., March 8, 2006; 26(10): 2788 - 2797.
[Abstract] [Full Text] [PDF]
Z. Zuo
The Role of Opioid Receptor Internalization and {beta}-Arrestins in the Development of Opioid Tolerance
Anesth. Analg., September 1, 2005; 101(3): 728 - 734.
[Abstract] [Full Text] [PDF]
C. A. McClung, E. J. Nestler, and V. Zachariou
Regulation of Gene Expression by Chronic Morphine and Morphine Withdrawal in the Locus Ceruleus and Ventral Tegmental Area
J. Neurosci., June 22, 2005; 25(25): 6005 - 6015.
[Abstract] [Full Text] [PDF]
B. Bie, Y. Peng, Y. Zhang, and Z. Z. Pan
cAMP-Mediated Mechanisms for Pain Sensitization during Opioid Withdrawal
J. Neurosci., April 13, 2005; 25(15): 3824 - 3832.
[Abstract] [Full Text] [PDF]
F. Frenois, L. Stinus, F. Di Blasi, M. Cador, and C. Le Moine
A Specific Limbic Circuit Underlies Opiate Withdrawal Memories
J. Neurosci., February 9, 2005; 25(6): 1366 - 1374.
[Abstract] [Full Text] [PDF]
M. Roberto, S. G. Madamba, D. G. Stouffer, L. H. Parsons, and G. R. Siggins
Increased GABA Release in the Central Amygdala of Ethanol-Dependent Rats
J. Neurosci., November 10, 2004; 24(45): 10159 - 10166.
[Abstract] [Full Text] [PDF]
J.-H. Ye, F. Wang, K. Krnjevic, W. Wang, Z.-G. Xiong, and J. Zhang
Presynaptic Glycine Receptors on GABAergic Terminals Facilitate Discharge of Dopaminergic Neurons in Ventral Tegmental Area
J. Neurosci., October 13, 2004; 24(41): 8961 - 8974.
[Abstract] [Full Text] [PDF]
E. C. Dumont and J. T. Williams
Noradrenaline Triggers GABAA Inhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area
J. Neurosci., September 22, 2004; 24(38): 8198 - 8204.
[Abstract] [Full Text] [PDF]
T. Nagai, K. Yamada, M. Yoshimura, K. Ishikawa, Y. Miyamoto, K. Hashimoto, Y. Noda, A. Nitta, and T. Nabeshima
From The Cover: The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release
PNAS, March 9, 2004; 101(10): 3650 - 3655.
[Abstract] [Full Text] [PDF]
M. Roberto, P. Schweitzer, S. G. Madamba, D. G. Stouffer, L. H. Parsons, and G. R. Siggins
Acute and Chronic Ethanol Alter Glutamatergic Transmission in Rat Central Amygdala: an In Vitro and In Vivo Analysis
J. Neurosci., February 18, 2004; 24(7): 1594 - 1603.
[Abstract] [Full Text] [PDF]
M. Melis, M. Pistis, S. Perra, A. L. Muntoni, G. Pillolla, and G. L. Gessa
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
J. Neurosci., January 7, 2004; 24(1): 53 - 62.
[Abstract] [Full Text] [PDF]
C. A. Bolanos, L. I. Perrotti, S. Edwards, A. J. Eisch, M. Barrot, V. G. Olson, D. S. Russell, R. L. Neve, and E. J. Nestler
Phospholipase C{gamma} in Distinct Regions of the Ventral Tegmental Area Differentially Modulates Mood-Related Behaviors
J. Neurosci., August 20, 2003; 23(20): 7569 - 7576.
[Abstract] [Full Text] [PDF]
J. M. Harrison, R. G. Allen, M. J. Pellegrino, J. T. Williams, and O. J. Manzoni
Chronic Morphine Treatment Alters Endogenous Opioid Control of Hippocampal Mossy Fiber Synaptic Transmission
J Neurophysiol, May 1, 2002; 87(5): 2464 - 2470.
[Abstract] [Full Text] [PDF]
T. Z. Shaw-Lutchman, M. Barrot, T. Wallace, L. Gilden, V. Zachariou, S. Impey, R. S. Duman, D. Storm, and E. J. Nestler
Regional and Cellular Mapping of cAMP Response Element-Mediated Transcription during Naltrexone-Precipitated Morphine Withdrawal
J. Neurosci., May 1, 2002; 22(9): 3663 - 3672.
[Abstract] [Full Text] [PDF]
M. Melis, R. Camarini, M. A. Ungless, and A. Bonci
Long-Lasting Potentiation of GABAergic Synapses in Dopamine Neurons after a Single In Vivo Ethanol Exposure
J. Neurosci., March 15, 2002; 22(6): 2074 - 2082.
[Abstract] [Full Text] [PDF]
L. Pu, G.-B. Bao, N.-J. Xu, L. Ma, and G. Pei
Hippocampal Long-Term Potentiation Is Reduced by Chronic Opiate Treatment and Can Be Restored by Re-Exposure to Opiates
J. Neurosci., March 1, 2002; 22(5): 1914 - 1921.
[Abstract] [Full Text] [PDF]
J. P. Wetherington and N. A. Lambert
Differential Desensitization of Responses Mediated by Presynaptic and Postsynaptic A1 Adenosine Receptors
J. Neurosci., February 15, 2002; 22(4): 1248 - 1255.
[Abstract] [Full Text] [PDF]
A. Tozzi, E. Guatteo, L. Caputi, G. Bernardi, and N. B. Mercuri
Group I mGluRs Coupled to G Proteins Are Regulated by Tyrosine Kinase in Dopamine Neurons of the Rat Midbrain
J Neurophysiol, June 1, 2001; 85(6): 2490 - 2497.
[Abstract] [Full Text] [PDF]
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev, January 1, 2001; 81(1): 299 - 343.
[Abstract] [Full Text] [PDF]
Y. Shoji, J. Delfs, and J. T. Williams
Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal
J. Neurosci., March 15, 1999; 19(6): 2347 - 2355.
[Abstract] [Full Text] [PDF]
G. Martin, R. Przewlocki, and G. R. Siggins
Chronic Morphine Treatment Selectively Augments Metabotropic Glutamate Receptor-Induced Inhibition of N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Nucleus Accumbens
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 30 - 35.
[Abstract] [Full Text]
S. L. Ingram, C. W. Vaughan, E. E. Bagley, M. Connor, and M. J. Christie
Enhanced Opioid Efficacy in Opioid Dependence Is Caused by an Altered Signal Transduction Pathway
J. Neurosci., December 15, 1998; 18(24): 10269 - 10276.
[Abstract] [Full Text] [PDF]
S. Numan, S. B. Lane-Ladd, L. Zhang, K. H. Lundgren, D. S. Russell, K. B. Seroogy, and E. J. Nestler
Differential Regulation of Neurotrophin and trk Receptor mRNAs in Catecholaminergic Nuclei during Chronic Opiate Treatment and Withdrawal
J. Neurosci., December 15, 1998; 18(24): 10700 - 10708.
[Abstract] [Full Text] [PDF]
B. Chieng and J. T. Williams
Increased Opioid Inhibition of GABA Release in Nucleus Accumbens during Morphine Withdrawal
J. Neurosci., September 1, 1998; 18(17): 7033 - 7039.
[Abstract] [Full Text] [PDF]
R. Tao, Z. Ma, and S. B. Auerbach
Alteration in Regulation of Serotonin Release in Rat Dorsal Raphe Nucleus after Prolonged Exposure to Morphine
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 481 - 488.
[Abstract] [Full Text]
|
|
|
|
 |
|